33 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
concerned Member States in which the trial is to be conducted for their review. Part II is assessed separately by the competent authorities and Ethics … , comprehensive information cannot be provided, or it would be contrary to generally accepted principles of medical ethics to collect such information
8-K
EX-1.1
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
governmental agency or any institutional review board, ethics committee or other similar entity which could lead to the termination, suspension, or material
8-K
EX-10.3
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
, committee charters, corporate governance, ethics, conflict of interest, confidentiality, share ownership and trading policies and guidelines and other
6-K
EX-1.1
AUTL
Autolus Therapeutics plc
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
communication from any Regulatory Authority or any other governmental agency or any institutional review board, ethics committee or other similar entity
6-K
EX-1
kdy5q4by
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-1.1
ve9zvnf3 owta
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-99.2
s2h7k4pl
5 Nov 20
Index to Condensed Consolidated Financial Statements
4:03pm
6-K
EX-1.1
ah2hq8gq1a7e6
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
6-K
EX-1
rcqh51
26 May 20
Current report (foreign)
4:31pm
6-K
k4dw5z
7 May 20
Index to Condensed Consolidated Financial Statements
12:00am
6-K
EX-1.1
ynr7yk
24 Jan 20
Autolus Announces Proposed Public Offering in the United States
4:06pm
424B4
uyq8rj6h
11 Apr 19
Prospectus supplement with pricing info
4:10pm
F-1
onok8q du8o293
8 Apr 19
Registration statement (foreign)
4:34pm
F-1
EX-1.1
p48 599o1tvw
8 Apr 19
Registration statement (foreign)
4:34pm
6-K
EX-1
unvgrcxv9w6
15 Mar 19
Annual Report and Accounts
5:26pm